OmniAb, Inc.
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
OABI$5.10-3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(in thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating activities: | ||
| Net loss | $(64,779) | $(62,033) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 21,754 | 23,583 |
| Share-based compensation | 15,824 | 21,499 |
| Amortization of discounts on short-term investments, net | (858) | (1,498) |
| Deferred income taxes, net | (1,529) | (9,040) |
| Change in estimated fair value of contingent liabilities | 325 | (2,547) |
| Gain on sale of ion channel asset | (3,000) | — |
| Other | 761 | 544 |
| Changes in operating assets and liabilities, net: | ||
| Accounts receivable, net | 189 | (625) |
| Prepaid expenses and other current assets | (1,109) | 642 |
| Other long-term assets | 628 | 645 |
| Accounts payable, accrued expenses, and other liabilities | (231) | (2,410) |
| Operating lease liabilities | (2,830) | (2,436) |
| Deferred revenue | (1,600) | (5,988) |
| Net cash used in operating activities | (36,455) | (39,664) |
| Investing activities: | ||
| Purchases of short-term investments | (46,858) | (40,288) |
| Proceeds from maturity of short-term investments | 50,800 | 78,000 |
| Purchases of property and equipment | (565) | (1,875) |
| Payments of contingent liabilities | — | (400) |
| Proceeds from sale of short-term investments | 90 | 2,447 |
| Proceeds from sale of ion channel asset | 3,000 | — |
| Net cash provided by investing activities | 6,467 | 37,884 |
| Financing activities: | ||
| Payments of contingent liabilities | (450) | (75) |
| Proceeds from issuance of common stock from stock plans | 489 | 3,257 |
| Taxes paid related to net share settlement of equity awards | — | (960) |
| Proceeds from issuance of common stock in private placement, net of commissions | 28,199 | — |
| Proceeds from issuance of common stock under ATM facility, net of commissions | — | 11,369 |
| Payment of transaction costs | (324) | (571) |
| Net cash provided by financing activities | 27,914 | 13,020 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (2,074) | 11,240 |
| Cash, cash equivalents and restricted cash at beginning of year | 28,158 | 16,918 |
| Cash, cash equivalents and restricted cash at end of year | $26,084 | $28,158 |
| Supplemental cash flow information: | ||
| Right-of-use assets obtained in exchange for operating lease obligations | $— | $39 |
| Deferred revenue recorded in accounts receivable | $2,307 | $732 |
| Supplemental non-cash investing and financing activities: | ||
| Purchase of fixed assets recorded in accounts payable | $47 | $77 |
| Transaction cost recorded in accounts payable | $— | $15 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.